About Us

Supriya Lifescience Limited headquartered in Mumbai, India is a public listed generic pharmaceutical company established in 1987 dedicated to developing, commercializing APIs & FDFs to treat patients with various diseases and infections. The API facility located at Lote, Maharashtra, India is multiple times USFDA, EDQM/EUGMP approved, and Health Canada approved.

Read More Watch Video

Area of Focus

API

FDF

CDMO
40+

Products

86+

Countries

1500+

Customers

22%

& above CAGR since 2019

400+

Employee Strength

We have a global footprint that extends across 86 countries

APIs

FDF

Awards

Latest News

8 July 2024

Pharma industry experts eye budget boost for innovation and global ambitions

Read More

4 July 2024

Budget 2024: Pharma sector demands substantial R&D incentives, tax relief and strong IP framework

Read More

25 June 2024

Our primary goal is to double our revenue, enter higher-margin niche segments and increase footprint: Dr. Saloni Wagh, Director, Supriya Lifescience Ltd.

Read More

29 May 2024

Supriya Life Q4 (YoY) | नतीजों पर सुप्रिया लाइफसाइंस मैनेजमेंट के साथ खास बातचीत | Boardroom

Watch Now

29 May 2024

Supriya Lifescience के Q4 Results, नए टाईअप, FY25 के ग्रोथ प्लान पर Director Saloni Wagh का Outlook

Watch Now

28 Mar 2024

Supriya Lifesci Standalone March 2024 Net Sales at Rs 158.18 crore, up 11.18% Y-o-Y

Read More

27 Mar 2024

Subsidise Employment For Women: FICCI FLO Wants To Add More Women To Workforce To Boost GDP

Read More

Several awards for excellence and outstanding performance.

Established in the year 1987, Supriya Lifescience Ltd. is a global leading manufacturer of Active pharmaceutical Ingredients. Our state-of-the-art facility is certified by USFDA, EDQM, EUGMP, NMPA & Health Canada. Facility is located in Khed, District Ratnagiri and headquartered in Mumbai, India.

Read More
BSE
NSE